Pomdoctor Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	366.86	342.56	304.85	245.22	215.38	141.21
Revenue Growth (YoY)	12.13%	12.37%	24.32%	13.85%	52.53%	-23.89%
Cost of Revenue	315.19	294.86	266.13	190.36	162.88	87.48
Gross Profit	51.67	47.69	38.72	54.86	52.51	53.72
Selling, General & Admin	74.78	68.24	55.99	54.87	102.95	292.16
Research & Development	2.97	3	3.37	3.59	4.28	1.99
Operating Expenses	77.75	71.25	59.36	58.46	107.23	294.14
Operating Income	-26.08	-23.55	-20.64	-3.59	-54.73	-240.42
Interest Expense	-13.26	-12.96	-13.85	-16.02	-16.29	-14
Other Non Operating Income (Expenses)	0.38	1.39	-0.85	-0.21	-0.22	-1.47
EBT Excluding Unusual Items	-38.96	-35.13	-35.34	-19.83	-71.24	-255.88
Gain (Loss) on Sale of Investments	-	-	-0.5	-	-	-
Asset Writedown	-4.26	-2.24	-1.11	-	-24.94	-
Other Unusual Items	-105.68	-105.97	-108.44	-105.68	-92.24	-0.6
Pretax Income	-148.9	-143.34	-145.39	-125.51	-188.42	-256.48
Earnings From Continuing Operations	-148.9	-143.34	-145.39	-125.51	-188.42	-256.48
Minority Interest in Earnings	0	-0.03	-0	0	0.02	0.04
Net Income	-148.9	-143.36	-145.39	-125.51	-188.4	-256.44
Net Income to Common	-148.9	-143.36	-145.39	-125.51	-188.4	-256.44
Shares Outstanding (Basic)	38	38	38	24	24	103
Shares Outstanding (Diluted)	38	38	38	24	24	103
Shares Change (YoY)	56.11%	-	56.11%	-	-76.35%	-
EPS (Basic)	-3.93	-3.79	-3.84	-5.18	-7.77	-2.50
EPS (Diluted)	-3.93	-3.79	-3.84	-5.18	-7.77	-2.50
Free Cash Flow	-20.51	-16.17	-45.91	-22.02	-15.68	-34.8
Free Cash Flow Per Share	-0.54	-0.43	-1.21	-0.91	-0.65	-0.34
Gross Margin	14.08%	13.92%	12.70%	22.37%	24.38%	38.05%
Operating Margin	-7.11%	-6.88%	-6.77%	-1.47%	-25.41%	-170.26%
Profit Margin	-40.59%	-41.85%	-47.69%	-51.18%	-87.47%	-181.61%
Free Cash Flow Margin	-5.59%	-4.72%	-15.06%	-8.98%	-7.28%	-24.64%
EBITDA	-25.95	-23.42	-20.53	14.08	-37.05	-221.86
EBITDA Margin	-7.07%	-6.84%	-6.73%	5.74%	-17.20%	-157.12%
D&A For EBITDA	0.13	0.13	0.11	17.68	17.68	18.56
EBIT	-26.08	-23.55	-20.64	-3.59	-54.73	-240.42
EBIT Margin	-7.11%	-6.88%	-6.77%	-1.47%	-25.41%	-170.26%
Revenue as Reported	366.86	342.56	304.85	245.22	-	-
Advertising Expenses	-	11.1	3.43	1.37	7.29	215

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q